The Top 10 Biotechnology/Pharmaceutical Deals

Pharmaceutical companies are usually always in news. Stil the top slot of companies are taken by Johnson & Johnson, Pfizer, Roche, and GlaxoSmithKline in the world.


Here are the Top 10 Biotechnology/Pharmaceutical Acquisition Deals of All time.

Acquired Company (Origin)	Targeted Company (Origin)	Deal Amount
Pfizer (United States)	Wyeth (United States)	$68 billion in cash and stock
Roche (Switzerland)	Genentech (United States)	$47 billion
Novartis (Switzerland)	Alcon  (United States)	$39.3 billion
AstraZeneca(United Kingdom)	MedImmune(United States)	$15.2 billion
Abbott(IL, USA)	Solvay Pharmaceuticals(Belgium)	$6.2 billion
Johnson & Johnson (United States)	Centocor Ortho Biotech, Inc(United States)	$4.9 billion in stock-for-stock exchange
Sanofi-aventis(Paris, France)	Merck & Co.(United States)	$4 billion
Abbott(United States)	Piramal Healthcare(India)	$3.72 billion for 4 years
GlaxoSmithKline(United Kingdom)	Stiefel Labs(United States)	$3.6 billion.
Warner Chilcott(United States)	Procter & Gamble's(P&G)(United States)	$3.1 billion

Further Info, Recently, the Abbott, US based company and India’s second largest Pharmaceutical company acquired the Indian Pharmaceutical company Piramal Healthcare Inc for a deal of $3.72 billion which includes the company get $400

million from Abbott for the next 4 years for providing an readymade presence to Abbott.